Amorphical aims to become a world leader in the prevention and treatment of metabolic and metastatic bone diseases through research and development of Amorphous Calcium Carbonate (ACC), a highly bioavailable, unique bio-mineral.
Amorphical’s three guiding principles: innovation, integrity and quality.
We continually invest in research and development of further novel applications of our ACC-based technology in order to deliver better solutions for a wide-range of calcium-related disorders.
We operate with transparency, respect and fairness with our customers, partners, employees and investors.
We are committed to manufacturing high-quality products which ensure their efficacy and safety while maintaining a fair price.